GSA Capital Partners’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
67,808
+49,409
| +269% | +$249K | 0.02% | 1178 |
|
|
2025
Q1 | $119K | Buy |
+18,399
| New | +$119K | 0.01% | 1476 |
|
|
2023
Q4 | – | Sell |
-117,131
| Closed | -$1.1M | – | 1963 |
|
|
2023
Q3 | $1.1M | Buy |
+117,131
| New | +$1.1M | 0.09% | 347 |
|
|
2022
Q1 | – | Sell |
-13,925
| Closed | -$583K | – | 1865 |
|
|
2021
Q4 | $583K | Sell |
13,925
-14,608
| -51% | -$612K | 0.07% | 507 |
|
|
2021
Q3 | $1.24M | Buy |
28,533
+23,032
| +419% | +$1M | 0.13% | 204 |
|
|
2021
Q2 | $260K | Buy |
+5,501
| New | +$260K | 0.03% | 1033 |
|